Ethnic Variations in Antidepressant Response
Maneno muhimu
Kikemikali
Maelezo
Depressed patients vary substantially in their responses to antidepressants. Genetic factors may account for a large part of these differences in response. This study will include both African Americans and Caucasians to examine the role of genetic factors in treatment response.
Participants receive citalopram (Celexa) for 8 weeks and a placebo for 1 week. Visits occur once a week for 11 weeks. A variety of interviews, scales, tests, and questionnaires are used to assess participants.
Tarehe
Imethibitishwa Mwisho: | 07/31/2009 |
Iliyowasilishwa Kwanza: | 10/10/2002 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 10/14/2002 |
Iliyotumwa Kwanza: | 10/15/2002 |
Sasisho la Mwisho Liliwasilishwa: | 08/02/2009 |
Sasisho la Mwisho Lilichapishwa: | 08/03/2009 |
Tarehe halisi ya kuanza kwa masomo: | 05/31/2002 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 10/31/2006 |
Tarehe ya Kukamilisha Utafiti: | 10/31/2006 |
Hali au ugonjwa
Uingiliaji / matibabu
Drug: Citalopram
Awamu
Vikundi vya Arm
Mkono | Uingiliaji / matibabu |
---|---|
Active Comparator: Citalopram All subjects receive an FDA approved dose of Citalopram | Drug: Citalopram PDA Approved antidepressant |
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 18 Years Kwa 18 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - DSM-IV criteria for Major Depression - African-American or Caucasian ethnic background (both parents and 3 out of 4 grandparents) Exclusion Criteria: - Schizophrenia, schizophreniform disorder, schizoaffective disorder, schizotypal disorder, psychotic depression, or bipolar disorder - Current drug abuse or history of drug abuse within the past 6 months - Unstable medical or neurological conditions that interfere with the treatment of depression - Allergy to citalopram - Failure to respond to adequate citalopram drug trial (40 mg for at least 6 weeks) - Seizure disorder - Pregnancy - Psychotropic medications, including antidepressants and neuroleptics - Suicidal ideation or other safety issues - Fluoxetine (Prozac) or MAOIs (Nardil, Parnate) in the last 2 months - Ongoing cognitive behavioral therapy or intensive psychotherapy. General talk therapy is acceptable |
Matokeo
Hatua za Matokeo ya Msingi
1. Hamilton Rating Scale for Depression [Measured weekly for 11 weeks]